International collaboration for global accessibility of COVID-19 vaccines.
作者信息
Zhou Qi
机构信息
Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, China Editorial Board Member of NSR.
出版信息
Natl Sci Rev. 2020 Aug;7(8):1269. doi: 10.1093/nsr/nwaa147. Epub 2020 Jul 8.
Abstract
摘要
相似文献
1
International collaboration for global accessibility of COVID-19 vaccines.
Natl Sci Rev. 2020 Aug;7(8):1269. doi: 10.1093/nsr/nwaa147. Epub 2020 Jul 8.
2
Digital data-based strategies: A novel form of better understanding COVID-19 pandemic and international scientific collaboration.
PLoS One. 2021 Apr 1;16(4):e0249280. doi: 10.1371/journal.pone.0249280. eCollection 2021.
3
A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa.
Global Health. 2021 Apr 8;17(1):42. doi: 10.1186/s12992-021-00666-8.
4
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.
Vaccine. 2020 Sep 3;38(39):6184-6189. doi: 10.1016/j.vaccine.2020.07.028. Epub 2020 Jul 31.
5
Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
BMJ. 2020 Dec 15;371:m4750. doi: 10.1136/bmj.m4750.
6
All together to Fight COVID-19.
Am J Trop Med Hyg. 2020 Jun;102(6):1181-1183. doi: 10.4269/ajtmh.20-0281.
7
A timely update of global COVID-19 vaccine development.
Emerg Microbes Infect. 2020 Dec;9(1):2379-2380. doi: 10.1080/22221751.2020.1838246.
8
Frontiers in the COVID-19 vaccines development.
Exp Hematol Oncol. 2020 Sep 3;9:24. doi: 10.1186/s40164-020-00180-4. eCollection 2020.
9
Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy.
Health Promot Perspect. 2020 Nov 7;10(4):300-305. doi: 10.34172/hpp.2020.48. eCollection 2020.
10
Ethical limits to placebo use and access to Covid-19 vaccines as a human right.
Indian J Med Ethics. 2021 Apr-Jun;VI(2):1-14. doi: 10.20529/IJME.2021.027.
引用本文的文献
1
Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development.
Mol Ther Nucleic Acids. 2025 Mar 28;36(2):102527. doi: 10.1016/j.omtn.2025.102527. eCollection 2025 Jun 10.
2
Innovative public strategies in response to COVID-19: A review of practices from China.
Health Care Sci. 2024 Dec 18;3(6):383-408. doi: 10.1002/hcs2.122. eCollection 2024 Dec.
3
The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges.
Mol Ther Nucleic Acids. 2024 Aug 8;35(3):102295. doi: 10.1016/j.omtn.2024.102295. eCollection 2024 Sep 10.
4
Biochemical and histopathological evaluation of ChAdOx1-S and BBIBP-CorV vaccination in normal and streptozotocin-induced diabetic Wistar rats.
PLoS One. 2023 May 4;18(5):e0284601. doi: 10.1371/journal.pone.0284601. eCollection 2023.
5
Impacts of worldwide individual non-pharmaceutical interventions on COVID-19 transmission across waves and space.
Int J Appl Earth Obs Geoinf. 2022 Feb;106:102649. doi: 10.1016/j.jag.2021.102649.
6
Public Health Measures and the Control of COVID-19 in China.
Clin Rev Allergy Immunol. 2023 Feb;64(1):1-16. doi: 10.1007/s12016-021-08900-2. Epub 2021 Sep 18.
7
COVID-19 and Quality of Life: Twelve Reflections.
Appl Res Qual Life. 2021;16(1):1-11. doi: 10.1007/s11482-020-09898-z. Epub 2021 Jan 6.
Zotero 插件